The Kitalys Institute

Kinexum founded the not-for-profit Kitalys (“ki-TA-lis”) Institute to preserve health, protect against disease, and prolong healthspan (healthy lifespan). Kitalys works to promote scientific advancements and translate them into material, accessible improvements to public health. 

Kitalys focuses on metabesity, the constellation of chronic diseases associated with aging, such as diabetes, obesity, and cancer. Many of these conditions share roots and so are susceptible to the same interventions. Kitalys hopes to increase healthspan by targeting metabesity as a whole, rather than any of its constituent diseases alone. 

The Kitalys Institute’s current work comprises the following: 

Targeting Healthy Longevity (formerly Targeting Metabesity or the Metabesity Conferences) is a series of cross-disciplinary, livestreamed discussions between a variety of leaders in the healthspan space, including scientists, policymakers, regulators, and business executives. Sessions are free and held throughout the year. Anyone can register to attend as a guest and learn of the newest developments in longevity research and innovation. To learn more, visit this page or the Targeting Healthy Longevity website. 

Project Healthspan advocates for policies encouraging and accelerating the development of drugs, devices, and supplements that support healthy longevity. In collaboration with the Healthspan Action Coalition (HSAC), the Kitalys Institute has drafted the THRIVE Act, which establishes a tiered system to expedite the approval of healthspan products while still ensuring safety and effectiveness. For more information on the THRIVE Act, visit the Kitalys website. 

Project Endpoints focuses on identifying quantifiable markers of aging (or its absence) in the body, which can serve as endpoints for medical research and the approval of health products. Consensus on these endpoints is required to facilitate new innovations that extend healthspan. The Kitalys Institute connects researchers and regulators who study different age-related chronic diseases to discuss such endpoints. 

With these three initiatives (and others to follow), Kitalys helps knock down the barriers preventing research on metabesity and its application to public policy. 

Science says we can. Industry says we should. Public health says we must.